[Inactivation of tumor suppressor genes in uterine cervix carcinogenesis]

R Chuaqui1, M Cuello, M Emmert-Buck

  • 1Departamento de Anatomía Patológica, Pontificia Universidad Católica de Chile. rchuaqui@med.puc.cl

Revista Medica De Chile
|June 3, 2000
PubMed

Insights

Inactivation of tumor suppressor genes is crucial in cervical cancer development. Advanced techniques reveal frequent genetic deletions in up to 95% of cervical cancers, even in early stages.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Context:

  • Cervical cancer development is linked to HPV oncogenes, but tumor suppressor gene (TSG) inactivation is less understood.
  • Genetic deletions are a primary mechanism for TSG inactivation.

Purpose:

  • To review the significance of tumor suppressor gene inactivation in cervical cancer progression.
  • To highlight the evolution of techniques for detecting genetic deletions in cervical carcinomas.

Summary:

  • Conventional methods like RFLP and Southern Blot underestimate TSG deletions due to limitations in analyzing pure tumor cells.
  • Sensitive approaches, including tissue microdissection and PCR analysis of microsatellites, demonstrate frequent genetic deletions (up to 95%) in cervical cancers.
  • These deletions occur at multiple chromosomal loci (3p, 5p, 6p, 11q) and are present in precursor lesions (cervical intraepithelial neoplasia, CIN).
  • Specific deletions correlate with prognostic factors like stage and invasion depth.

Impact:

  • Cervical carcinogenesis is a multistep process involving both oncogene activation and tumor suppressor gene inactivation.
  • Understanding these genetic events provides insights into cervical cancer pathogenesis and potential therapeutic targets.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...